Castle Rock Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-7,256	Closed	-$254K	–	29
2018 Q3	$254K	Sell	7,256 -3,066	-30%	-$107K	0.4%	94
2018 Q2	$607K	Buy	10,322 +1,902	+23%	+$112K	0.83%	33
2018 Q1	$385K	Buy	+8,420	New	+$385K	0.64%	55